| Jacqueline Fisher, | |
|
2900 C Ct, Ashtabula, OH 44004-4575 | |
| (440) 536-4176 | |
| (440) 536-4187 |
| Full Name | Jacqueline Fisher |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2900 C Ct, Ashtabula, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578056776 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 12925 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Fisher, 1520 Riverside Dr, Painesville, OH 44077-5180 Ph: (440) 749-1353 | Jacqueline Fisher, 2900 C Ct, Ashtabula, OH 44004-4575 Ph: (440) 536-4176 |
News Archive
ManTech International Corporation today completed the acquisition of Evolvent Technologies, Inc. of Herndon, Va., a focused healthcare-systems integrator with particular strength in federal healthcare systems.
Cellectis, the French genome engineering specialist, has announced today that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide right to use inventions related to TAL effector-mediated DNA recognition and cleavage. This revolutionary approach for the targeted modification of genomes was developed by the University of Minnesota and Iowa State University.
What comes naturally to most people - to think and then do - is difficult for stroke patients who have lost the full use of their limbs. New research by Rice University, the University of Houston (UH) and TIRR Memorial Hermann aims to help victims recover that ability to the fullest extent possible with a $1.17 million grant from the National Institutes of Health (NIH) and the President's National Robotics Initiative (NRI).
Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that its board of directors has approved an extension of its share repurchase program through December 1, 2009.
In photographs of the eye used to screen for diabetes-related eye disease, separating out the red color channel can help show some abnormalities—especially in racial/ethnic minority patients, suggests a study in the February issue of Optometry and Vision Science, official journal of the American Academy of Optometry.
› Verified 6 days ago
Noreen Fish, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2630 W 13th St, Ashtabula, OH 44004 Phone: 440-992-2160 | |
Jennifer Vera Korth, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4533 Park Ave, Ashtabula, OH 44004 Phone: 888-873-4221 | |
Mr. Kevin M Welsh, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2240 Wade Ave, Ashtabula, OH 44004 Phone: 440-993-1240 | |
Kateri Z. Wladyka, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2900 Donahoe Dr, Ashtabula, OH 44004 Phone: 440-992-4433 Fax: 440-992-6307 | |
Leslie A Skidmore, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2300 Wade Ave, Ashtabula, OH 44004 Phone: 440-994-9321 | |
Mrs. Suzanne Marcin, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4200 State Rd, Ashtabula, OH 44004 Phone: 440-536-5716 | |
Ms. Rhonda Kay Szabo, M.A. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2304 Wade Ave, Ashtabula, OH 44004 Phone: 440-992-1250 |